Navigation Links
US and European Bariatric (Obesity) Surgical Devices Industry
Date:12/12/2011

Bariatric Surgery - Ultimate Option for Obesity Treatment 64

Growth Drivers 64

Market Restraints 65

Rapid Growth in Bariatric Surgery Devices Market 65

Bariatric Surgery - Fast Facts 66

Surgery for Adolescent Obesity- Slow & Steady Growth 66

An Insight into Gastric Banding Market 66

Economic Crisis & Gastric Banding Market 67

Patient Support 67

Single Incision Surgery 67

Competitive Surgical Procedures 68

Studies Suggest Lowering Restrictions on AGB 68

Laparoscopic Adjustable Gastric Banding Gains Popularity 68

ASCs Face Formidable Challenges 69

LGB Vs LGBP - Cost Comparison 69

Robot-Assisted Gastric Bypass Surgery Rises in Popularity 69

Reimbursement Scenario 69

Insurance Coverage 70

CMS Offers Coverage for Bariatric Surgery 70

Lack of Sufficient Coverage - A Major Obstacle 71

Competition Intensifies in the US Gastric Banding Market 71

Table 20: Leading Gastric Banding Devices in the US (2010):

Percentage Share Breakdown of Procedure Volume (includes

corresponding Graph/Chart) 72

Allergan Gains Approval for Extending Target Population for

Lap-Band Surgery 72

Product Launches 73

Strategic Corporate Developments 75

Key Players 77

Allergan, Inc. 77

Ethicon Endo-Surgery, Inc. 77

PARÉ Surgical, Inc. 77

Satiety, Inc. 78

B.Market Analytics 78

Table 21: US Recent Past, Current & Future Analysis for

Bariatric Surgery: Annual Number of Gastric Bypass and

Gastric Banding Procedures for Years 2009 through 2017 (in

Thousands) (includes corresponding Graph/Chart) 78

Table 22: US Historic Review for Bariatric Surgery: Annual

Number of Gastric Bypass and Gastric Banding Procedures for

Years 2003 through 2008 (in Thousands) (includes

corresponding Graph/Chart) 79

Table 23: US
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. Nonin Medical Announces the European Launch of EQUANOX Advance™ Neonatal/Pediatric Sensor for Regional Oximetry at PGA Conference
2. The European Commission Grants Marketing Authorization for DIFICLIR™ (fidaxomicin) Tablets for Treatment of Clostridium difficile Infections
3. ULURU Inc. Extends the European Altrazeal® License to Include Australia and New Zealand
4. Ampio Pharmaceuticals Awarded European Patent that Strengthens Intellectual Property Protection for its key drug Ampion™
5. Avanafil Data Presented at the European Society of Sexual Medicine Meeting
6. European Medicines Agencys (EMA) Committee for Human Medicinal Products (CHMP)Tentatively Scheduled to Render an Opinion on PixuvriTM Marketing Authorization Application on January 19, 2012
7. CardioInsight Announces CE Mark Clearance and European Launch of the ECVUE™ Non-Invasive Electrocardiographic Mapping System
8. Omeros Announces Submission to European Medicines Agency of Paediatric Investigation Plan Letter of Intent for OMS302
9. Delcath Announces Agreement With European Institute of Oncology for Initial Launch of Hepatic Chemosat Delivery System in the European Union
10. X-ray Equipment - Top 5 European Markets
11. Amsterdam Molecular Therapeutics Receives Orphan Designation in the European Union for Hemophilia B Gene Therapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... 25, 2014 Cardinal Health will today name ... winners of its prestigious Independent Pharmacy Best Practices Competition, ... of the nation,s largest gatherings of independent pharmacists. ... pharmacies from Ohio , ... – were selected for implementing exceptionally creative methods that ...
(Date:7/25/2014)... July 25, 2014 According to ... "Global and China Insulin Market (Rapid-Acting, Short-Acting, Intermediate-Acting, Long-Acting, ... Share, Growth, Trends and Forecast (Value and Volume), 2013 ... USD 19.99 billion in 2012 and is expected to ... 2019 to reach USD 32.24 billion in 2019. ...
(Date:7/25/2014)... Laboratories, Inc. (NASDAQ: IDXX ) today reported ... 11% versus the prior year period to $390 million. ... of 2014 versus the prior year period was 9%, ... . Earnings per diluted share ("EPS") for the quarter ... year period to $1.10."In the second quarter, we continued ...
Breaking Medicine Technology:Cardinal Health Announces Three Best Practice Winners for Leading Change in Community Pharmacy 2Cardinal Health Announces Three Best Practice Winners for Leading Change in Community Pharmacy 3Cardinal Health Announces Three Best Practice Winners for Leading Change in Community Pharmacy 4Cardinal Health Announces Three Best Practice Winners for Leading Change in Community Pharmacy 5Cardinal Health Announces Three Best Practice Winners for Leading Change in Community Pharmacy 6Global Insulin Market Expected to Reach USD 32.24 Billion Globally in 2019: Transparency Market Research 2Global Insulin Market Expected to Reach USD 32.24 Billion Globally in 2019: Transparency Market Research 3Global Insulin Market Expected to Reach USD 32.24 Billion Globally in 2019: Transparency Market Research 4IDEXX Laboratories Announces Second Quarter Results 2IDEXX Laboratories Announces Second Quarter Results 3IDEXX Laboratories Announces Second Quarter Results 4IDEXX Laboratories Announces Second Quarter Results 5IDEXX Laboratories Announces Second Quarter Results 6IDEXX Laboratories Announces Second Quarter Results 7IDEXX Laboratories Announces Second Quarter Results 8IDEXX Laboratories Announces Second Quarter Results 9IDEXX Laboratories Announces Second Quarter Results 10IDEXX Laboratories Announces Second Quarter Results 11IDEXX Laboratories Announces Second Quarter Results 12IDEXX Laboratories Announces Second Quarter Results 13IDEXX Laboratories Announces Second Quarter Results 14IDEXX Laboratories Announces Second Quarter Results 15IDEXX Laboratories Announces Second Quarter Results 16IDEXX Laboratories Announces Second Quarter Results 17IDEXX Laboratories Announces Second Quarter Results 18IDEXX Laboratories Announces Second Quarter Results 19IDEXX Laboratories Announces Second Quarter Results 20IDEXX Laboratories Announces Second Quarter Results 21IDEXX Laboratories Announces Second Quarter Results 22IDEXX Laboratories Announces Second Quarter Results 23IDEXX Laboratories Announces Second Quarter Results 24IDEXX Laboratories Announces Second Quarter Results 25IDEXX Laboratories Announces Second Quarter Results 26IDEXX Laboratories Announces Second Quarter Results 27IDEXX Laboratories Announces Second Quarter Results 28
... Study Reveals that Thoracic Endoluminal Grafting is a Feasible Alternative ... TO Open Surgical Repair, J Vasc Surg. 2007 Sep; 46(3):413-20. ... JA, Olsen DM, Shtutman A, Lucas LA, Wheatley G, Alpern J, Ramaiah V, Diethrich ... ...
... The National Institute of,Standards and Technology (NIST) ... in the Commerce Department,s Advanced Technology Program,(ATP), a ... awarded to the early-phase Michigan biotechnology company developing,drug ... and,other bone disorders. Velcura scientists have discovered ...
Cached Medicine Technology:Video: The Arizona Heart Institute Announces the Largest Worldwide Experience with Endoluminal Grafting to Treat Thoracic Aortic Aneurysms and Related Pathologies 2Video: The Arizona Heart Institute Announces the Largest Worldwide Experience with Endoluminal Grafting to Treat Thoracic Aortic Aneurysms and Related Pathologies 3Video: The Arizona Heart Institute Announces the Largest Worldwide Experience with Endoluminal Grafting to Treat Thoracic Aortic Aneurysms and Related Pathologies 4Video: The Arizona Heart Institute Announces the Largest Worldwide Experience with Endoluminal Grafting to Treat Thoracic Aortic Aneurysms and Related Pathologies 5Video: The Arizona Heart Institute Announces the Largest Worldwide Experience with Endoluminal Grafting to Treat Thoracic Aortic Aneurysms and Related Pathologies 6NIST Awards $2 Million to Velcura Therapeutics, Inc. for Innovative Technology R&D - Dual-Action Therapies for Bone Disease 2
(Date:7/25/2014)... 2014 On July 22, 2014, ... client and the nation’s number one provider of ... announced their partnership with TransAct Merchant Solutions’ National ... ISO/MSP of Chase Paymentech Solutions, LLC, which provides ... Companies that are members of TransAct’s National Association ...
(Date:7/25/2014)... 25, 2014 This is a ... of the Galactooligosaccharides (GOS) industry in Global ... of the industry, including definitions, applications and industry ... market analysis are provided with a focus on ... market. A comparison between the international and Chinese ...
(Date:7/25/2014)... Philadelphia, PA (PRWEB) July 25, 2014 ... that Valerie D. Weber, MD, MS, FACP, has been appointed ... , Weber will join Drexel from The Commonwealth Medical College, ... Sciences, associate dean for clinical affairs, and professor of medicine. ... of The Commonwealth Medical College, Weber had a major role ...
(Date:7/25/2014)... workers, especially men, may be at higher risk for type ... new study suggests. Also at special risk are shift ... moving around at various times of the day. The ... Alan Manevitz, a clinical psychiatrist at Lenox Hill Hospital in ... shifts disrupts many key body chemicals, creating a ripple effect ...
(Date:7/25/2014)... --, Treatment for lymphoma may lower men,s fertility, new ... which are cancers of the body,s white blood cells, ... reproductive years. For men, treatment for these cancers can ... their fertility within two years of treatment, the researchers ... of this significant side effect before treatment begins. ...
Breaking Medicine News(10 mins):Health News:Nuanced Media Client, CEDR HR Solutions, Partners with TransAct to Serve Medical, Dental, and Eye Care Professionals 2Health News:GOS Market (Galacto-oligosaccharides) Development in Global & China Regions Now Available at DeepResearchReports.com 2Health News:GOS Market (Galacto-oligosaccharides) Development in Global & China Regions Now Available at DeepResearchReports.com 3Health News:Valerie D. Weber, MD, Appointed Vice Dean for Education at Drexel University College of Medicine 2Health News:Valerie D. Weber, MD, Appointed Vice Dean for Education at Drexel University College of Medicine 3Health News:Study Links Shift Work to Risk for Type 2 Diabetes 2Health News:Study Links Shift Work to Risk for Type 2 Diabetes 3Health News:Lymphoma Treatment May Harm, Halt Men's Sperm Production 2
... ALEXANDRIA, Va., Feb. 12 An article published in ... the American Medical Association helps physicians to better ... determine which end-of-life care options may be best for ... life have increased in recent years. With more ...
... Calif., Feb. 12 Fisher Vista, LLC, a marketing,and ... human resource,industries today announced that Kevin Grossman, who has ... president of its HRmarketer.com division. , ... overall responsibility of,HRmarketer.com and the HRmarketer Services Group. ...
... BASKING RIDGE, N.J., Feb. 12 Regado Biosciences, ... President and Chief Executive Officer, will be presenting ... Philadelphia, PA on Friday, February 20, 2009, at ... a review of the Company,s lead development product, ...
... of prescribing system to avoid ,alert fatigue, , , ... override electronic medication safety alerts and rely instead ... patients, which suggests that physicians find the alerts ... , Researchers looked at the electronic prescriptions ...
... 2009 Oral-B(R) Stages, the dental,professional,s #1 recommended ... a campaign in recognition of National Children,s Dental ... about the state of children,s,oral health in America, ... parents and,healthcare providers alike. In fact, tooth ...
... 12 Kovarus, Inc., a premier,technology consulting firm, and ... today jointly announced the launch of a new bike ... awareness of a good cause,the American Brain Tumor Association ... http://www.newscom.com/cgi-bin/prnh/20080708/AQTU138LOGO ) , The Studio ...
Cached Medicine News:Health News:JAMA Article Provides Guidance to Physicians on End-of-Life Care 2Health News:Kevin Grossman Named President of HRmarketer.com 2Health News:Docs Override Most Electronic Drug Warnings 2Health News:Oral-B Addresses Children's Oral Health Needs at All Stages of Development During National Children's Dental Health Month 2Health News:Oral-B Addresses Children's Oral Health Needs at All Stages of Development During National Children's Dental Health Month 3Health News:Oral-B Addresses Children's Oral Health Needs at All Stages of Development During National Children's Dental Health Month 4Health News:Oral-B Addresses Children's Oral Health Needs at All Stages of Development During National Children's Dental Health Month 5Health News:Oral-B Addresses Children's Oral Health Needs at All Stages of Development During National Children's Dental Health Month 6Health News:Biking for Fun, Sport, and Brain Tumor Awareness 2Health News:Biking for Fun, Sport, and Brain Tumor Awareness 3
The Vitek 2 is a fully automated bacteriology system that performs bacterial identification and susceptibility testing analysis using a standard inoculum. It detects resistance and helps combat bacte...
IDS Rapid Yeast Plus, a microbial identification system....
IDS Rapid NH, a microbial identification system....
The Cogent Microbial Luminescence System (MLS) is a superior Rapid microbial detection system for UHT product screening combining proven technology of ATP-bioluminescence with unsurpassed hardware in...
Medicine Products: